JUL 23, 2021 12:07 PM PDT

Repurposed Antibiotics Show Promise Against Skin Cancer

WRITTEN BY: Annie Lennon

In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in treating melanoma. The study was published in the Journal of Experimental Medicine

Over time, some melanoma cells escape treatment by ‘turning off’ their proliferation systems and effectively hiding from the immune system to strike back at a later stage. To survive this inactive state, however, these cells rely on their mitochondria, the so-called ‘power plants’ of cells. As mitochondria are derived from bacteria that migrated into cells, they are vulnerable to certain antibiotics. 

With this vulnerability in mind, the researchers thought to see if they could treat certain cancer cells with antibiotics. In experiments, they implanted patient-derived tumors into mice, and then treated them with antibiotics, either by themselves or in combination with pre-existing therapies for melanoma. 

"The antibiotics quickly killed many cancer cells and could thus be used to buy the precious time needed for immunotherapy to kick in. In tumors that were no longer responding to targeted therapies, the antibiotics extended the lifespan of -- and in some cases even cured -- the mice," said Eleonora Leucci, one of the authors of the study. 

The researchers used antibiotics that are rarely used to treat bacterial infections due to the rise of antibiotic resistance. They noted that cancer cells showed no resistance to these antibiotcs in their study, and thus may be repurposed for cancer. 

The researchers also made note of a patient who used doxycycline to treat a bacterial infection. In addition to treating their infection, the researchers said that the antibiotics re-sensitized a resistant melanoma lesion to standard therapy in the patient. 

"Our findings are based on research in mice, so we don't know how effective this treatment is in human beings,” says Leucci, “This result is cause for optimism, but we need more research and clinical studies to examine the use of antibiotics to treat cancer patients.”

 

Sources: Journal of Experimental MedicineScience Daily

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUN 10, 2021
Clinical & Molecular DX
Algorithm Flags High Risk of Pancreatic Cancer
JUN 10, 2021
Algorithm Flags High Risk of Pancreatic Cancer
In 2021, over 60,000 individuals in the U.S. alone will be diagnosed with pancreatic cancer. Researchers are turning to ...
JUL 12, 2021
Cell & Molecular Biology
A Molecule From the Gut Microbiome May Fight Tumors
JUL 12, 2021
A Molecule From the Gut Microbiome May Fight Tumors
The more we learn abut the gut microbiome, the more it seems that the microorganisms in our gastrointestinal tracts can ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
JUL 26, 2021
Genetics & Genomics
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
JUL 26, 2021
A Region of Non-Coding DNA That May Help Regulate Telomere Length is ID'ed
Many types of cells have to be replenished continuously throughout our lives, and the genome in the nucleus of those cel ...
AUG 13, 2021
Drug Discovery & Development
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
AUG 13, 2021
Breast Cancer Drug Reverses Deadly Blood Cancer in Mice
A drug currently used to treat advanced breast cancers may treat a rare type of leukemia known as myelofibrosis. The stu ...
SEP 16, 2021
Technology
Scientists Create Tiny Replicas Of The Pancreas To Study New Drugs
SEP 16, 2021
Scientists Create Tiny Replicas Of The Pancreas To Study New Drugs
Pancreatic cancer it’s often hard to diagnose in its early stages, resulting in patients having more advanced canc ...
Loading Comments...